PHS recommends preventive drugs for HIV exposures.
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006282:Health Personnel / Q000592:standards*; D006801:Humans; D019469:Indinavir; D019259:Lamivudine; D016273:Occupational Exposure; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology; D014492:United States Public Health Service; D014779:Virus Replication / Q000187:drug effects / Q000502:physiology; D016047:Zalcitabine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D015215:Zidovudine / Q000494:pharmacology / Q000627:therapeutic use*